| Hans-Günter Meyer-Thompson | Verschiedene
Psilocybin study enrolls clinicians with COVID-linked blues
Psilocybin study enrolls clinicians with COVID-linked blues
Enrollment has begun in a small study of whether psilocybin-assisted psychotherapy can help alleviate symptoms of depression and anxiety that front-line clinicians developed during the COVID-19 pandemic. (University of Washington School of Medicine, USA, 14.12.2021)
https://medicalxpress.com/news/2021-12-psilocybin-enrolls-clinicians-covid-linked-blues.html